Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.68 USD | -7.18% | -13.85% | -11.11% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 3.57M | Capitalization | 138M |
---|---|---|---|---|---|
Net income 2024 * | -122M | Net income 2025 * | -125M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 38.7 x |
P/E ratio 2024 * |
-0.91
x | P/E ratio 2025 * |
-0.9
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.58% |
Latest transcript on Adicet Bio, Inc.
1 day | -7.18% | ||
1 week | -13.85% | ||
Current month | -28.51% | ||
1 month | -25.00% | ||
3 months | -33.60% | ||
6 months | +31.25% | ||
Current year | -11.11% |
Managers | Title | Age | Since |
---|---|---|---|
Aya Jakobovits
FOU | Founder | 71 | 14-10-31 |
Chen Schor
CEO | Chief Executive Officer | 51 | 16-06-30 |
Brian Harvey
DFI | Director of Finance/CFO | 63 | 20-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steve Dubin
BRD | Director/Board Member | 70 | 20-09-14 |
Carl Gordon
CHM | Chairman | 59 | 15-08-14 |
Michael Kauffman
BRD | Director/Board Member | 60 | 21-11-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.68 | -7.18% | 1,248,017 |
24-04-25 | 1.81 | -3.47% | 851,580 |
24-04-24 | 1.875 | -10.71% | 1,478,484 |
24-04-23 | 2.1 | +5.00% | 1,130,428 |
24-04-22 | 2 | +2.56% | 325,351 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.11% | 149M | |
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |
- Stock Market
- Equities
- ACET Stock